Progress and prospects: foamy virus vectors enter a new age

Gene Ther. 2010 Dec;17(12):1423-9. doi: 10.1038/gt.2010.95. Epub 2010 Jul 15.

Abstract

Foamy viruses, distantly related to the major subfamily of Retroviruses, Orthoretroviruses that include oncoviruses (for example, murine leukemia virus (MLV)) and lentiviruses (human immunodeficiency virus (HIV)), are endemic in mammalian species, but not in human populations. Humans infected by accidental or occupational exposure remain well. The virus is not transmitted to others, nor is it associated with any disease. These features added to its broad host range, efficient transduction of progenitor cells and an integration profile less likely to induce insertional mutagenesis, make these viruses attractive as vectors. Long-term reversal of disease phenotype in dogs with the genetic defect, leukocyte adhesion deficiency, by foamy virus vector therapy strengthens the case for their clinical exploitation.

Publication types

  • Review

MeSH terms

  • Animals
  • Gene Transfer Techniques / standards
  • Gene Transfer Techniques / trends
  • Genetic Diseases, Inborn / therapy*
  • Genetic Therapy / methods
  • Genetic Therapy / standards
  • Genetic Therapy / trends
  • Genetic Vectors / genetics
  • Genetic Vectors / standards
  • Genetic Vectors / therapeutic use*
  • Humans
  • Spumavirus / genetics*
  • Spumavirus / pathogenicity